block randomisation Search Results


digital en-block randomisation system  (EBD Group)
90
EBD Group digital en-block randomisation system
Digital En Block Randomisation System, supplied by EBD Group, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/digital en-block randomisation system/product/EBD Group
Average 90 stars, based on 1 article reviews
digital en-block randomisation system - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
stratified randomised permuted block design  (SAS institute)
90
SAS institute stratified randomised permuted block design
Stratified Randomised Permuted Block Design, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stratified randomised permuted block design/product/SAS institute
Average 90 stars, based on 1 article reviews
stratified randomised permuted block design - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
block-balanced randomisation  (StatsDirect ltd)
90
StatsDirect ltd block-balanced randomisation
Block Balanced Randomisation, supplied by StatsDirect ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/block-balanced randomisation/product/StatsDirect ltd
Average 90 stars, based on 1 article reviews
block-balanced randomisation - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
balanced block randomisation  (Tillotts Pharma AG)
90
Tillotts Pharma AG balanced block randomisation
Characteristics of included studies [ordered by study ID]
Balanced Block Randomisation, supplied by Tillotts Pharma AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/balanced block randomisation/product/Tillotts Pharma AG
Average 90 stars, based on 1 article reviews
balanced block randomisation - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
block randomisation lists  (GraphPad Software Inc)
90
GraphPad Software Inc block randomisation lists

Block Randomisation Lists, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/block randomisation lists/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
block randomisation lists - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
block randomisation  (Intersect Australia Ltd)
90
Intersect Australia Ltd block randomisation

Block Randomisation, supplied by Intersect Australia Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/block randomisation/product/Intersect Australia Ltd
Average 90 stars, based on 1 article reviews
block randomisation - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
blocked randomisation  (SAS institute)
90
SAS institute blocked randomisation

Blocked Randomisation, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/blocked randomisation/product/SAS institute
Average 90 stars, based on 1 article reviews
blocked randomisation - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
block balanced randomisation codes  (Catalent Pharma Solutions)
90
Catalent Pharma Solutions block balanced randomisation codes

Block Balanced Randomisation Codes, supplied by Catalent Pharma Solutions, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/block balanced randomisation codes/product/Catalent Pharma Solutions
Average 90 stars, based on 1 article reviews
block balanced randomisation codes - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
computerbased block randomisation  (SAS institute)
90
SAS institute computerbased block randomisation

Computerbased Block Randomisation, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/computerbased block randomisation/product/SAS institute
Average 90 stars, based on 1 article reviews
computerbased block randomisation - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
unified blocked randomisation codes sas v.9.1  (SAS institute)
90
SAS institute unified blocked randomisation codes sas v.9.1

Unified Blocked Randomisation Codes Sas V.9.1, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/unified blocked randomisation codes sas v.9.1/product/SAS institute
Average 90 stars, based on 1 article reviews
unified blocked randomisation codes sas v.9.1 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
block randomisation and allocation of patients to treatment and control groups  (Klinge Pharma GmbH)
90
Klinge Pharma GmbH block randomisation and allocation of patients to treatment and control groups

Block Randomisation And Allocation Of Patients To Treatment And Control Groups, supplied by Klinge Pharma GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/block randomisation and allocation of patients to treatment and control groups/product/Klinge Pharma GmbH
Average 90 stars, based on 1 article reviews
block randomisation and allocation of patients to treatment and control groups - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
block randomisation method  (SAS institute)
90
SAS institute block randomisation method

Block Randomisation Method, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/block randomisation method/product/SAS institute
Average 90 stars, based on 1 article reviews
block randomisation method - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Characteristics of included studies [ordered by study ID]

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet: Characteristics of included studies [ordered by study ID]

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Blocking Assay, Control, Activity Assay

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Blocking Assay, Control, Capsules, Labeling

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Generated, Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Blocking Assay, Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Sequencing, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Generated, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Generated, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules, Membrane

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Membrane, Activity Assay

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Capsules, Control, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Generated, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Software, Control, Capsules, Membrane

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Software, Control, Capsules, Membrane

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Blocking Assay, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Capsules, Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Generated, Produced, Filtration, Control, Emulsion

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Selection, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Labeling, Capsules, Control, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Generated, Sequencing, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Clinical Proteomics, Control

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet:

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Sequencing, Selection, Generated, Introduce

Aggarwal 2003 CKD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Aggarwal 2003 CKD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Direct Antiglobulin Test, Sequencing, Selection

Ahsan 1997 TX

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Ahsan 1997 TX

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Sequencing, Selection

Broumand 1998 HD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Broumand 1998 HD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Infection, Sequencing, Selection

Erten 1998 HD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Erten 1998 HD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Sequencing, Selection

Fishbane 1995 HD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Fishbane 1995 HD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Sequencing, Selection

Fudin 1998 HD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Fudin 1998 HD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Sequencing, Selection, Generated

Hussain 1998 HD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Hussain 1998 HD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Sequencing, Selection

Kotaki 1997 HD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Kotaki 1997 HD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Sequencing, Selection

Li 2008 HD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Li 2008 HD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Infection, Sequencing, Selection

Li 2008 PD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Li 2008 PD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Infection, Sequencing, Selection

Lye 2000 HD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Lye 2000 HD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Infection, Sequencing, Selection

Macdougall 1996 HD,PD,CKD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Macdougall 1996 HD,PD,CKD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Infection, Sequencing, Selection

Macdougall 1999 HD,PD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Macdougall 1999 HD,PD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Sequencing, Selection

McMahon 2009 CKD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: McMahon 2009 CKD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Sequencing, Selection, Blocking Assay, Generated

Michael 2007 HD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Michael 2007 HD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Sequencing, Selection

Mudge 2009 TX

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Mudge 2009 TX

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Concentration Assay, Sequencing, Selection

Nagaraju 2013 CKD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Nagaraju 2013 CKD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Infection, Sequencing, Selection, Generated

Pisani 2014 CKD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Pisani 2014 CKD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Clinical Proteomics, Infection, Sequencing, Selection, Generated

Qunibi 2011 CKD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Qunibi 2011 CKD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Infection, Sequencing, Selection

Souza 1997 HD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Souza 1997 HD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Sequencing, Selection

Svara 1996 HD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Svara 1996 HD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Sequencing, Selection

Tsuchida 2010 HD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Tsuchida 2010 HD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Transplantation Assay, Sequencing, Selection

Wang 2003 HD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Wang 2003 HD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Sequencing, Selection

Warady 2002 HD

Journal: The Cochrane Database of Systematic Reviews

Article Title: Parenteral versus oral iron therapy for adults and children with chronic kidney disease

doi: 10.1002/14651858.CD007857.pub3

Figure Lengend Snippet: Warady 2002 HD

Article Snippet: Random sequence generation (selection bias) , Low risk , Simple block randomisation from block randomisation lists generated with Graphpad Statmate.

Techniques: Infection, Sequencing, Selection